ANG Lifesciences Announces Board Meeting to Review Q1 Results and Imposes Trading Restrictions
ANG Lifesciences India Ltd has scheduled a Board of Directors meeting to review its un-audited financial performance for the quarter ended June 30, 2026. The company also announced the closure of its trading window ahead of the results announcement.The Board Meeting is set to take place on Friday, August 14, 2026, at 05:00 P.M. Attendees will consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter. The agenda also includes discussion of any other business that may be necessary with the permission of the Chairman.
The company has confirmed that the trading window is closed effective July 1, 2026. This closure period will extend until 48 hours following the publication of the results on August 14, 2026.
Stock Price Movement
As of 12:43, ANG Lifesciences India Ltd is ticking up, trading at ₹32.65, which represents a solid 1.49% gain today. The shares navigated the day's market activity, finding support between the intraday low of ₹32.00 and the high mark of ₹33.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.